Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Amand F. Schmidt; Lucy S. Pearce; John T. Wilkins; Juan P. Casas; Aroon D. Hingorani

doi:10.1136/heartjnl-2017-312858

Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Amand F. Schmidt^*, Lucy S. Pearce, John T. Wilkins, Juan P. Casas, Aroon D. Hingorani

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	1053-1055
Number of pages	3
Journal	Heart
Volume	104
Issue number	13
DOIs	https://doi.org/10.1136/heartjnl-2017-312858
State	Published - 2018

Funding

Health Sciences Fellow. ADH is an NIHR Senior Investigator and is funded by the UCL Hospitals NIHR Biomedical Research Centre. Competing interests None declared. Provenance and peer review Not commissioned; externally peer reviewed. data sharing statement All data are available at: http://www.cochrane.org/CD011748/VASC_pcsk9-inhibitors-prevention-cardiovascular-disease. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. funding AFS is funded by UCLH NIHR Biomedical

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/heartjnl-2017-312858

Cite this

@article{fa01776881df45d1976ca111a5e4587a,

title = "Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease",

author = "Schmidt, {Amand F.} and Pearce, {Lucy S.} and Wilkins, {John T.} and Casas, {Juan P.} and Hingorani, {Aroon D.}",

note = "Funding Information: Health Sciences Fellow. ADH is an NIHR Senior Investigator and is funded by the UCL Hospitals NIHR Biomedical Research Centre. Competing interests None declared. Provenance and peer review Not commissioned; externally peer reviewed. data sharing statement All data are available at: http://www.cochrane.org/CD011748/VASC_pcsk9-inhibitors-prevention-cardiovascular-disease. {\textcopyright} Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. Funding Information: funding AFS is funded by UCLH NIHR Biomedical",

year = "2018",

doi = "10.1136/heartjnl-2017-312858",

language = "English (US)",

volume = "104",

pages = "1053--1055",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishing Group",

number = "13",

}

TY - JOUR

T1 - Cochrane corner

T2 - PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

AU - Schmidt, Amand F.

AU - Pearce, Lucy S.

AU - Wilkins, John T.

AU - Casas, Juan P.

AU - Hingorani, Aroon D.

N1 - Funding Information: Health Sciences Fellow. ADH is an NIHR Senior Investigator and is funded by the UCL Hospitals NIHR Biomedical Research Centre. Competing interests None declared. Provenance and peer review Not commissioned; externally peer reviewed. data sharing statement All data are available at: http://www.cochrane.org/CD011748/VASC_pcsk9-inhibitors-prevention-cardiovascular-disease. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. Funding Information: funding AFS is funded by UCLH NIHR Biomedical

PY - 2018

Y1 - 2018

UR - http://www.scopus.com/inward/record.url?scp=85048337179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048337179&partnerID=8YFLogxK

U2 - 10.1136/heartjnl-2017-312858

DO - 10.1136/heartjnl-2017-312858

M3 - Editorial

C2 - 29444808

AN - SCOPUS:85048337179

SN - 1355-6037

VL - 104

SP - 1053

EP - 1055

JO - Heart

JF - Heart

IS - 13

ER -

Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this